Research and Markets: Pharmaceutical Market in India by 2020: A Healthy Decade

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/9f4046/pharmaceutical_mar) has announced the addition of the "Pharmaceutical Market in India by 2020: A Healthy Decade" report to their offering.

Market Highlights:

The Indian pharmaceutical market is highly regulated and fragmented, dominated by private Indian companies. Currently the domestic Indian Pharmaceutical market is valued at US$14.30 billion growing at a healthy double digit CAGR of 13% since 2005-06.

The major growth contributors are strong Indian demographics with robust economic YOY growth, increase in affordability of medicines, an increased percentage of disposable income being spent on healthcare and increased penetration of health insurance. The government has made public healthcare one of its top priorities by launching policies and programs aimed at making healthcare more affordable and accessible, especially in rural markets.

The global pharmaceuticals market is expected to grow at 7% to 8% CAGR over the next five years, reaching an anticipated US$ 1.7 trillion in 2020, India is going to rank among top 10 global player by 2015 itself. Looking at the immense potential Indian Pharmaceutical industry has, IKON estimates that India will emerge as a leading global player holding the rank among top 5 major global markets by 2020.

Key Topics Covered by "Pharmaceutical Market in India by 2020: A Healthy Decade":

This report begins with the current scenario of Pharmaceutical market in India covering current market size and structure, market drivers, challenges and competitive landscape.

Chapter 2 highlights factors leading to India's emergence as a major global player along with the global pharmaceuticals market overview.

The chapter 3 throws light on how growth will continue throughout the current decade. Chapter 4 focuses on the regulatory environment, dealing with the laws and regulations affecting Indian pharmaceuticals Industry.

Who Should Buy This Report:

Pharma Companies, Investors and Venture Capitalists, Industry Analysts & Consultants, Corporate and Entrepreneurs, Industry association, Education and Government Institutes

For more information visit http://www.researchandmarkets.com/research/9f4046/pharmaceutical_mar

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716